Andere talen Jenscare Scientific Co., Ltd.

Aandelen

9877

CNE100005KC9

Beurs gesloten - Hong Kong S.E. Andere beurzen 10:08:14 11-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
3,96 ^HKD	+2,06%		+1,28%	-82,16%

25/04	Jenscare Scientific's LuX-Valve aanvraag niet goedgekeurd door NMPA, aandelenkoersen dalen 11%	MT
27/03	Jenscare Scientific Co. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Jenscare Scientific's LuX-Valve Application Not Approved by NMPA, Share Prices Drop 11%	25/04
Jenscare Scientific Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
Jenscare Scientific's Mitral Valve Device Completes Enrollment for Confirmatory Clinical Trials	25/03
Jenscare Scientific Co., Ltd. Announces Completion of the Enrollment of JensClip for Confirmatory Clinical Trial and One-Month Follow-Up	25/03
Jenscare Scientific Secures HKEX Nod for H Share Circulation	19/03
Jenscare Scientific Co., Ltd. Completes the First Clinical Implantation in Brazil	28/02
Jenscare Scientific’s CEO, CFO Boost Stake in Firm	26/01
Jenscare Scientific Unit Concludes 1st Clinical Implantation of PFO Occluder System	03/01
Jenscare Scientific Co., Ltd. Completes the First Clinical Implantation of Omniseal	03/01
Jenscare Scientific to Buy Back Shares	29/12
Jenscare Scientific Shareholders Approve of Sale of 22.48% Interest in Congenital Heart Disease Device Maker	22/12
Jenscare Scientific to Divest 22.5% Stake in Medical Device Maker	29/11
Jenscare Releases Results of Confirmatory Trial for Tricuspid Valve Replacement in London Meet	28/11
Jenscare Scientific Co., Ltd. Announces One-Year Results of the Confirmatory Clinical Trial of the LuX-Valve Transcatheter Tricuspid Valve Replacement System	28/11
Jenscare Scientific Enrolls First Patient for Atrial Appendage Occluder System Trial	13/11
Jenscare Presents Results of Tricuspid Valve Replacement System at US Conference	31-10-23
Jenscare Scientific Co., Ltd. Announces Lux-Valve Plus Travel II Results Released At the 2023 TCT in the U.S	31-10-23
Jenscare Shares Surge 16% After China Grants Priority Approval for Aortic Heart Valve System	30-10-23
Jenscare Scientific Co., Ltd. Announces Registration Application of Ken-Valve, the Transcatheter Prosthetic Aortic Heart Valve System Successfully Enters the Priority Approval Process	30-10-23
Jenscare Scientific Applies Valve Replacement System Under Fee-for-Service Scheme in Asia-Pacific; Shares Tumble 9%	20-10-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Jenscare Scientific Co., Ltd.

Aandelen

9877

CNE100005KC9

Andere talen

Filters